Karma Research Team

The Karma Research Team writes plain-language summaries of published preclinical and laboratory research on the peptides and research compounds we supply. Articles draw on peer-reviewed literature and are checked against our Research Use Only policy before publishing. We do not provide medical advice or guidance on dosing or human use.

Professional header image for comparison analysis: CJC-1295 Without DAC vs. With DAC: What the Structural Di...

CJC-1295 With vs. Without DAC: Structural Differences

Selecting the wrong formulation of a CJC peptide does not simply introduce inconvenience; it introduces a fundamental mismatch between the pharmacokinetic profile you are working with and the biological endpoint you are trying to measure. CJC-1295 exists in two structurally distinct forms, and the presence or absence of the Drug Affinity Complex changes the compound’s

CJC-1295 With vs. Without DAC: Structural Differences Read More »

Professional header image for industry analysis: NAD+ Peptide Research: Mitochondrial Mechanisms and Why R...

NAD+ Peptide Research: Mitochondrial Mechanisms

Most researchers approaching NAD+ supplementation protocols treat it as a generalized longevity compound, cataloguing phenotypic outcomes without interrogating the enzymatic architecture driving them. That framing is insufficient for rigorous preclinical work. NAD+ occupies a structurally indispensable position in mitochondrial redox chemistry, sirtuin deacylation cascades, PARP-mediated genome surveillance, and circadian transcriptional feedback, and the term “nad

NAD+ Peptide Research: Mitochondrial Mechanisms Read More »

Professional header image for industry analysis: Cagrilintide: Mecanismo de Acción sobre el Receptor de Am...

Cagrilintide: Receptor de Amilina y Estudios Preclínicos

La convergencia de dos sistemas de saciedad neurobiológicamente distintos representa una de las oportunidades más prometedoras en farmacología metabólica contemporánea. El cagrilintide peptide, un análogo acilado de amilina de acción prolongada, no simplemente suma efectos a los agonistas del receptor GLP-1; activa circuitos hipotalámicos y del área postrema que codifican la saciedad mediante mecanismos fisiológicamente

Cagrilintide: Receptor de Amilina y Estudios Preclínicos Read More »

Professional header image for industry analysis: Inhibidores de NNMT en Investigación Metabólica: El Caso ...

Inhibidores de NNMT: El Caso del 5-Amino-1MQ

El metabolismo energético celular depende de una red de enzimas reguladoras cuya modulación selectiva abre nuevas posibilidades para la investigación preclínica. Entre estas enzimas, la nicotinamida N-metiltransferasa (NNMT) ha cobrado relevancia creciente por su papel central en el metabolismo del NAD+ y la diferenciación adipogénica. Sin embargo, las herramientas diseñadas para inhibirla permanecen prácticamente ausentes

Inhibidores de NNMT: El Caso del 5-Amino-1MQ Read More »

Scroll to Top